BioCentury | Aug 4, 2020
Product Development

Aug. 3 Quick Takes: CymaBay gains on PBC readout; plus expanded labels for Epidiolex, Spravato, Voyager-AbbVie deal ends, Immunic and more

...vivo research (see “Recursion to Expand into New Drug Discovery” ). Cytovia, CytoImmune’s CAR deal Cytovia...
...Inc. has acquired worldwide rights to CytoImmune Therapeutics’ EGFR dual-targeting chimeric antigen receptor (CAR) technology. Cytovia...
...cell therapy to treat glioblastoma and other solid tumors. CytoImmune will receive a stake in Cytovia...
BioCentury | Jun 13, 2020
Management Tracks

Sawyers to head AACR next year; plus Quell, CalciMedica, Bigfoot, Celyad, Praxis, Affimed and more

...position. He was VP, development sciences at Kymab Group Ltd. NK cell cancer immunotherapy company Cytovia...
...Ltd. American Association for Cancer Research CalciMedica Inc. Celyad S.A. Confo Therapeutics N.V. Praxis Precision Medicines Inc. Affimed N.V. Summit Therapeutics plc RenovaCare Inc. Cytovia...
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...mediated anti-inflammatory and anti-viral effects, Karyopharm said. Cytovia seeking NK cell solution NK cell company Cytovia Inc....
...to start clinical testing by year-end and make the therapy available to patients in 2021. Cytovia...
BioCentury | Jan 27, 2017
Company News

SATT Sud-Est, Immune Pharmaceuticals deal

...will target VEGF and the IL-8 family. Immune will fund the bispecific program through its Cytovia...
BioCentury | May 7, 2001
Strategy

Aurora's partners

...Aurora's partners Allergan American Home Products AntiCancer Becton Dickinson Bristol-Myers Ceres Clontech Cystic Fibrosis Foundation Cytovia...
BioCentury | May 7, 2001
Strategy

Aurora's partners

...Aurora's partners Allergan American Home Products AntiCancer Becton Dickinson Bristol-Myers Ceres Clontech Cystic Fibrosis Foundation Cytovia...
BioCentury | Feb 5, 2001
Company News

Genset management update

...Vick as VP of worldwide business development and licensing, formerly VP of corporate development at Cytovia Inc. WIR...
BioCentury | Jul 31, 2000
Company News

Cytovia, GPC Biotech deal

...Reverse Genomics technology to analyze the mode of action of an apoptosis-inducing compound from Cytovia. Cytovia...
...certain mammalian cell-based assay technologies for use in GPC's in-house and partnered drug discovery programs. Cytovia Inc....
BioCentury | Jul 25, 2000
Company News

GPC and Cytovia in oncology deal

...to analyze the mode of action of an apoptosis-inducing compound from Cytovia (San Diego, Calif.). Cytovia...
BioCentury | Jul 17, 2000
Company News

BioChem, Maxim Pharmaceuticals deal

...BCHE and MAXM's Cytovia Inc. subsidiary (San Diego, Calif.) will develop Cytovia's CV2105 series of small molecules...
Items per page:
1 - 10 of 25
BioCentury | Aug 4, 2020
Product Development

Aug. 3 Quick Takes: CymaBay gains on PBC readout; plus expanded labels for Epidiolex, Spravato, Voyager-AbbVie deal ends, Immunic and more

...vivo research (see “Recursion to Expand into New Drug Discovery” ). Cytovia, CytoImmune’s CAR deal Cytovia...
...Inc. has acquired worldwide rights to CytoImmune Therapeutics’ EGFR dual-targeting chimeric antigen receptor (CAR) technology. Cytovia...
...cell therapy to treat glioblastoma and other solid tumors. CytoImmune will receive a stake in Cytovia...
BioCentury | Jun 13, 2020
Management Tracks

Sawyers to head AACR next year; plus Quell, CalciMedica, Bigfoot, Celyad, Praxis, Affimed and more

...position. He was VP, development sciences at Kymab Group Ltd. NK cell cancer immunotherapy company Cytovia...
...Ltd. American Association for Cancer Research CalciMedica Inc. Celyad S.A. Confo Therapeutics N.V. Praxis Precision Medicines Inc. Affimed N.V. Summit Therapeutics plc RenovaCare Inc. Cytovia...
BioCentury | Apr 8, 2020
Deals

COVID-19 roundup: U.S. to freeze WHO funding as Wellcome calls on CEOs to support $8B fund; plus Ridgeback-Emory, Karyopharm, IQVia and more

...mediated anti-inflammatory and anti-viral effects, Karyopharm said. Cytovia seeking NK cell solution NK cell company Cytovia Inc....
...to start clinical testing by year-end and make the therapy available to patients in 2021. Cytovia...
BioCentury | Jan 27, 2017
Company News

SATT Sud-Est, Immune Pharmaceuticals deal

...will target VEGF and the IL-8 family. Immune will fund the bispecific program through its Cytovia...
BioCentury | May 7, 2001
Strategy

Aurora's partners

...Aurora's partners Allergan American Home Products AntiCancer Becton Dickinson Bristol-Myers Ceres Clontech Cystic Fibrosis Foundation Cytovia...
BioCentury | May 7, 2001
Strategy

Aurora's partners

...Aurora's partners Allergan American Home Products AntiCancer Becton Dickinson Bristol-Myers Ceres Clontech Cystic Fibrosis Foundation Cytovia...
BioCentury | Feb 5, 2001
Company News

Genset management update

...Vick as VP of worldwide business development and licensing, formerly VP of corporate development at Cytovia Inc. WIR...
BioCentury | Jul 31, 2000
Company News

Cytovia, GPC Biotech deal

...Reverse Genomics technology to analyze the mode of action of an apoptosis-inducing compound from Cytovia. Cytovia...
...certain mammalian cell-based assay technologies for use in GPC's in-house and partnered drug discovery programs. Cytovia Inc....
BioCentury | Jul 25, 2000
Company News

GPC and Cytovia in oncology deal

...to analyze the mode of action of an apoptosis-inducing compound from Cytovia (San Diego, Calif.). Cytovia...
BioCentury | Jul 17, 2000
Company News

BioChem, Maxim Pharmaceuticals deal

...BCHE and MAXM's Cytovia Inc. subsidiary (San Diego, Calif.) will develop Cytovia's CV2105 series of small molecules...
Items per page:
1 - 10 of 25